Abstract
Eskimos of the east coast of Greenland very rarely had contacts with Caucasians until late in the 19th century. Their genes are therefore likely to be similar to those in the original Eskimo gene pool. We have compared serum concentrations of Lp(a) and apo(a) phenotypes in 78 East Greenland Eskimos (EGE) with those in Eskimos from Western Greenland (WGE) (n=100) and Caucasian Danes (n=466). Lp(a) levels were higher in EGE (median: 11.9 mg/dl [95% CI: 9.1–16.4]) than in Danes (p<0.01), (median: 6.3 mg/dl [95% CI: 5.5–7.3]) and WGE (p<0.01), (median: 7.8 mg/dl [95% CI: 5.7–10.2]). Lp(a) concentrations above 30 mg/dl were (p<0.05) more common in EGE (19%) than in WGE (9%) and similar (p=0.89) to those in Danes (20%). Apo(a) molecules as small as S2 or smaller (S1, B and F) were present in 26% of Danes and in 3% of WGE but were absent in EGE (p<0.01). In contrast, a large apo(a) variant (VS4) was present in 54% of EGE and 62% of WGE, whereas it was very rare in Danes (2%). Lp(a) concentrations were inversely associated with apo(a) size in EGE (p<0.05), WGE (p<0.01) and Danes (p<0.01), but EGE with S3 or S4 had significantly higher Lp(a) levels than Danes (p<0.05) with the same phenotypes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Loscalzo J. Lipoprotein(a): A unique risk factor for Atherothrobotic disease. Arteriosclerosis 1990; 10: 672–679.
Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein(a) and coronary heart disease: A prospective case-control study in a general population sample of middle aged men. Br Med J 1990; 301: 1248–1251.
Sigurdsson G, Baldursdottir A, Sigvaldason H, Agnarsson U, Thorgeirsson G, Sigfusson N. Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men. Am J Cardiol 1992; 69: 1251–1254.
Jauhiainen M, Koskinen P, Ehnholm C, Frick MH, Mänttäri M, Manninen V, Huttunen JK. Lipoprotein(a) and coronary heart disease risk: A nested case-control study of the Helsinki Heart Study participants. Atherosclerosis 1991; 89: 59–67.
Kwiterovich PO, Coresh J, Smith HH, Bachorik PS, Derby CA, Pearson TA. Comparison of plasma levels of alipopoproteins B and Al, and other risk factors in men and women with premature coronary artery disease. Am J Cardiol 1992; 69: 1015–1021.
Ridker PM, Hennekens CH, Stampfer MJ. A prospective study of lipoprotein(a) and risk of myocardial infarction. JAMA 1993; 270: 2195–2199.
Brown MS, Goldstein JL. Teaching old dogmas new tricks. Nature 1987; 330: 113–114.
Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) Glycoprotein phenotypes: Inheritance and relation to Lp(a) lipoprotein concentration in plasma. J Clin Invest 1987; 80: 458–465.
Lackner C, Boerwinkle E, Leffert CC, Rahmig T, Hobbs H. Molecular basis of apolipoprotein(a) isoform heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest 1991; 87: 2153–2161.
Kraft HG, Köchel S, Menzel HJ, Sandholzer C, Utermann G. A transcribed hypervariable locus controlling plasma lipoprotein(a) concentration. Hum Genet 1992; 90: 220–230.
Klausen IC, Gerdes LU, Schmidt EB, Dyerberg J, Faergeman O. Differences in apolipoprotein(a) polymorphism in west Greenland Eskimos and Caucasian Danes. Hum Genet 1992; 89: 384–388.
Middaugh JP. Cardiovascular deaths among Alaskan natives, 1980–86. Am J Public Health 1990; 80: 282–285.
Persson I. Anthropological investigations of the population of Greenland [Thesis]. University of Reykjavik, Iceland 1970.
Kraft HG, Dieplinger H, Hoye E, Utermann G. Lp(a)phenotyping by immunoblotting with polyclonal and monoclonal antibodies. Arteriosclerosis 1988; 8: 212–216.
Cambell MJ, Gardner JL. Calculating confidence intervals for some non-parametric analyses. In: Gardner MJ, Altman DG (eds), Statistics with confidence: Confidence intervals and statistical quidelines. London: Br Med J, 1990: 71–79.
Siegel S, Castellan Jr NJ. Nonparametric statistics for behavioral sciences 1. Singapore: McGraw-Hill 1988: 44–151.
Klausen IC, Hansen PS, Gerdes LU, Rüdiger N, Gregersen N, Faergeman O. A PvuII polymorphism of the low density lipoprotein receptor gene is not associated with plasma concentrations of low density lipoproteins including Lp(a). Hum Genet 1993; 91: 193–195.
Weiss KM. Genetic variation and human disease: Principles and evolutionary approaches. Cambridge, UK: Cambridge University Press, 1993.
Eriksson AW, Lehmann W, Simpson NE. Genetic studies on circumpolar populations. In: Milan FA (ed), The human biology of circumpolar populations. Cambridge, UK: Cambridge University Press, 1980: 81–168.
Harvald B. Genetic epidemiology of Greenland. Clin Genet 1989; 36: 364–367.
de Kniff P, Johansen LG, Rosseneu M, Frants RR, Jespersen J, Havekes LM. Lipoprotein profile of Greenland Inuit population: Influence of anthropometric variables, apo E and A4 polymorphism, and lifestyle. Arteriosclerosis and Thrombosis 1992; 12: 1371–1379.
Sandholzer C, Hallman DM, Sana N, Sigurdsson G, Lackner C, Császár A, Boerwinkle E, Utermann G. Effects of the apolipoprotein(a) size polymorphism on lipoprotein(a) concentration in 7 ethnic groups. Hum Genet 1991; 86: 607–614.
Helmhold M, Bigge J, Muche R, Mainoo J Thiery J, Seidel D, Armstrong VW. Contribution of the apo(a) phenotype to plasma Lp(a) concentrations shows considerable ethnic variation. J Lipid Res 1991; 32: 1919–1928.
Sandholzer C, Saha N, Kark JD, Rees A, Jaross W, Dieplinger H, Hoppichler F, Boerwinkle E, Utermann G: Apo(a) isoforms predict risk for coronary heart disease: A study of six poulations. Arterioscler Thromb 1992; 12: 1214–1226.
Marcovina SM, Albers JJ, Jacobs DR, Perkins LL, Lewis CE, Howard BV, Savage P. Lipoprotein(a) concentrations and Apolipoprotein(a) phenotypes in Caucasians and African Americans. Arterioscler Thromb 1993; 13: 1037–1045.
Rader DJ, Cain W, Zech LA, Usher D, Brewer Jr HB. Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein(a) isoform is determined by the rate of lipoprotin(a) production. J Clin Invest 1993; 91: 443–447.
Sandholzer C, Boerwinkle E, Saha N, Tong MC, Utermann G. Apolipoprotein(a) phenotypes, Lp(a) concentrations and plasma lipid levels in relation to coronary heart disease in a Chinese population: Evidence for the role of the apo(a) gene in coronary heart disease. J Clin Invest 1992; 89: 1040–1046.
Mölgaard J, Klausen IC, Lassvik C, Faergeman O, Gerdes LU, Olsson AG. Significant association between low-molecular weight apolipoprotein(a) isoforms and intermittent claudication. Arterioscler Thromb 1992; 12: 895–901.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Klausen, I.C., Hansen, P.S., Povlsen, J.V. et al. A unique pattern of apo(a) polymorphism in an isolated east Greenlandic inuit (Eskimo) population. Eur J Epidemiol 11, 563–568 (1995). https://doi.org/10.1007/BF01719309
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01719309